The International Mesothelioma Program is a center for mesothelioma at the Brigham and Women’s Hospital in Boston, Massachusetts.
Researchers have developed targeted treatment with heat-activated gold spheres (nanotubes) to help with killing mesothelioma tumors.
The phase II OT-101 clinical trial will study a promising treatment option for patients with pleural mesothelioma.
An anticipated new mesothelioma clinical trial involving a novel drug, RSO-021, will take place at the University of Vermont Cancer Center.
A new cancer treatment (known as monoclonal antibodies) is helping COVID-19 patients with underlying conditions avoid hospitalization.
A promising new artificial intelligence (AI) tool could streamline the process of identifying mesothelioma tumors in patients.
Scientists and researchers are testing new CAR-T cell treatment methods in clinical trials. Learn the timeline and what to expect.
Preliminary data from a study done by Targovax show a numerical advantage in Progression-Free Survival in patients treated with ONCOS-102.
Phase II of a clinical trial involving surgery, radiation, and chemotherapy is actively recruiting patients with pleural mesothelioma.
The combination of imaging features with a history of asbestos exposure may be enough information to diagnose pleural mesothelioma.